{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:34:11Z","timestamp":1785202451359,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.11.051","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T20:38:49Z","timestamp":1134679129000},"page":"2333-2342","source":"Crossref","is-referenced-by-count":26,"title":["Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb\/c mouse model of progressive pulmonary tuberculosis"],"prefix":"10.1016","volume":"24","author":[{"given":"L.D.","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Hernandez","family":"Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.051_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement: global burden of tuberculosis: estimated incidence, prevalence and mortality by country WHO Global Survaillence and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.051_bib2","first-page":"537","article-title":"Global surveillance for antituberculosis drug resistance, 1994\u20131997. World Health Organization\u2014International Union against tuberculosis and lung disease. Working group on anti-tuberculosis drug resistance-surveillance","volume":"338","author":"Pablos-Mendez","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.11.051_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.11.051_bib4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.8367727","article-title":"Cloning an M. tuberculosis DNA fragment associated with entry and survival inside cells","volume":"261","author":"Arruda","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.11.051_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2005.11.051_bib6","doi-asserted-by":"crossref","first-page":"10965","DOI":"10.1073\/pnas.94.20.10961","article-title":"Conditionally replicating mycobacteriophages: a system for transcriptase delivery to Mycobacterium tuberculosis","volume":"94","author":"Bardarov","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.051_bib7","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.94.20.10955","article-title":"Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis","volume":"94","author":"Pelicic","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.051_bib8","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1099\/00221287-148-10-3007","article-title":"Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis","volume":"148","author":"Bardarov","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2005.11.051_bib9","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1099\/00221287-146-8-1969","article-title":"Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement","volume":"146","author":"Parish","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2005.11.051_bib10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/IAI.69.2.1442-1150.2001","article-title":"Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates","volume":"69","author":"Smith","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.051_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.micinf.2004.11.007","article-title":"Mutation in mce genes attenuate M. tuberculosis virulence","volume":"7","author":"Gioffre","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2005.11.051_bib12","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1073\/pnas.2433882100","article-title":"Hypervirulent mutant of Mycobacterioum tuberculosis resulting from disruption of the mce1 operon","volume":"100","author":"Shimono","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2005.11.051_bib13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.11.051_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1086\/380413","article-title":"Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacilli Calmette-Guerin vaccine","volume":"189","author":"Pinto","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.051_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","article-title":"A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes","volume":"133","author":"L\u00f2pez","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2005.11.051_bib16","first-page":"26","article-title":"Correlation between the kinetics of Th1\/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis","volume":"89","author":"Hern\u00e1ndez Pando","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2005.11.051_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2567.1997.00193.x","article-title":"Analysis of the local kinetics and localization of interleukin 1 alpha, tumor necrosis factor alpha and transforming growth factor beta, during the course of experimental pulmonary tuberculosis","volume":"90","author":"Hern\u00e1ndez Pando","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2005.11.051_bib18","first-page":"84","article-title":"Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection","volume":"6","author":"Hern\u00e1ndez Pando","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.051_bib19","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial doses define the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"issue":"6034","key":"10.1016\/j.vaccine.2005.11.051_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/317262a0","article-title":"A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12","volume":"317","author":"Isberg","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2005.11.051_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.107.2.237","article-title":"A comparison of the growth of selected mycobacteria in HeLa, monkey kidney, and human amnion cells in tissue culture","volume":"107","author":"Shepard","year":"1958","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.051_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1574-695X.2002.tb00581.x","article-title":"Mycobacterium tuberculosis cell entry operon (mce) homologs in Mycobacterium other than tuberculosis","volume":"33","author":"Haile","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2005.11.051_bib23","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1099\/00221287-148-10-2997","article-title":"Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis","volume":"148","author":"Santangelo","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2005.11.051_bib24","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/IAI.71.10.6083-6087.2003","article-title":"Analysis of expression profile of mammalian cell entry (mce) operons of Mycobacterium tuberculosis","volume":"71","author":"Kumar","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.11.051_bib25","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1073\/pnas.2134250100","article-title":"Genetic requirements for mycobacterial survival during infection","volume":"100","author":"Sassetti","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.11.051_bib26","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.11.051_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nm868","article-title":"Building a better tuberculosis vaccine","volume":"9","author":"Young","year":"2003","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T16:17:21Z","timestamp":1586621841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05011990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X05011990"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}